on BASTIDE (EPA:BLC)
Strong Organic Growth of 7.1% for Groupe Bastide in Q1 2026-2027
Groupe Bastide reported a solid 7.1% organic growth in Q1 2026-2027, with revenues reaching €124.3 million. Home Healthcare Services, particularly Respiratory care and Diabetes, resulted in a 7.8% increase in this segment. Meanwhile, the Homecare segment achieved a 6.2% growth, fueled by robust store and healthcare institution performances.
Revenue details reveal Homecare reached €52.0 million, with healthcare institutions contributing €23.4 million, marking a 6.7% rise. Growth in wheelchair sales aided stores and online revenues of €28.6 million. Respiratory care surged by 10.6%, with international operations posting nearly 20% growth. Nutrition-Perfusion-Diabetes-Stomatherapy saw €26.4 million in revenue, a 4.7% increase.
Looking ahead, Bastide aims for at least €500 million in 2026-2027 revenues while preserving its operating margin through cost control and strategic expansion.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BASTIDE news